IVERIC bio, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€151.60M +53.8% N/A -€140.63M +66.0% N/A
    €0.00 +NaN% -€98.54M +35.1% N/A -€84.70M +48.6% N/A
    €0.00 +NaN% -€72.93M +43.6% N/A -€57.01M +36.3% N/A
    €0.00 +NaN% -€50.77M -193.3% N/A -€41.83M +15.7% N/A
    €0.00 -100.0% €54.42M -44.8% N/A -€36.15M -65.6% N/A
    €181.12M +312.5% €98.51M -159.0% 54.4% +4.3 pp -€105.08M +12.8% -58.0% +1.5 pp
    €43.91M -1.2% -€166.84M +83.0% -379.9% -1.7 pp -€93.18M +42.3% -212.2% -0.65 pp
    €44.43M +24.8% -€91.19M +7.7% -205.3% +0.33 pp -€65.48M -167.3% -147.4% -4.2 pp
    €35.59M +∞% -€84.70M +92.0% -238.0% -2.4 pp €97.25M -331.2% 273.3% +2.7 pp
    €0.00 +NaN% -€44.12M +251.2% N/A -€42.07M +272.2% N/A
    €0.00 +NaN% -€12.56M -21.8% N/A -€11.30M -31.5% N/A
    €0.00 -€16.07M N/A -€16.49M N/A

    Notifications